Novartis wants to amend invalidated patent for MS drug

Please login to bookmark Close

Novartis has applied to amend its proposed patent for an oral form of multiple sclerosis drug Gilenya, as it appeals an invalidity ruling by IP Australia for lack of inventive step.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

AMS doubles down on defence in vaginal mesh class action

Please login to bookmark Close

Medical device manufacturer American Medical Systems has reasserted that it cannot face claims under Australian consumer laws over its allegedly defective vaginal mesh products because it only supplied the products to a US subsidiary.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

IOOF liability ‘plain as a pike staff’, APRA says at start of trial

Please login to bookmark Close

The prudential regulator has opened the first day of its case against IOOF directors and entities by claiming the wealth manager’s liability is “plain as a pike staff”, as IOOF contends the regulator’s case is “artificial and theoretical” and “overly simplistic”.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

Ariosa infringed Sequenom’s patent for prenatal genetic test, court finds

Please login to bookmark Close

A court has found Ariosa Diagnostics infringed a patent held by Sequenom for a noninvasive prenatal genetic test, and ruled one claim of the patent invalid for lack of fair basis.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

Mondelez overvalued Aussie biz in $460M sale to Bega, suit claims

Please login to bookmark Close

Bega Cheese is accusing global food giant Mondelez of overstating the value of the Australian assets purchased for $460 million in July 2017 as part of a deal that’s also at the centre of an ongoing dispute with Kraft over peanut butter trade dress rights.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

‘Neglect, inexperience, incompetence’: IOOF unit faces $82M trial over plantation sale

Please login to bookmark Close

IOOF subsidiary Australian Executor Trustees (SA) is facing an $82 million claim for compensation by investors angered by the way the trustee handled the sale of a 42,000 hectare timber plantation run by collapsed forestry giant Gunns Group.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

Commercial interests shouldn’t bar consolidation, says Brambles class action judge

Please login to bookmark Close

A judge has released his reasons for consolidating two shareholder class actions against logistics company Brambles over opposition by the lead applicant in one of the competing cases, saying the interests of group members trumped those of the lawyers and funders in the case.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

ASIC appeals ruling in market manipulation case against NAB contractor Whitebox

Please login to bookmark Close

The Australian Securities and Investments Commission is challenging the dismissal of its enforcement action against  National Australia Bank contractor Whitebox Trading and sole director Johannes Boshoff, which accused them of market manipulation that resulted in a spike in the price of securities on the ASX-200 index in October 2012.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?